Dr Art Rastinehad joins On Focus to discuss how focal therapy is being implemented in the US, and how US and UK clinicians and researchers are collaborating to advance its development.

Dr Art Rastinehad is Director for Prostate Cancer at the Northwell Health Cancer Institute in New York State and the Vice Chair of Urology at Lenox Hill Hospital in New York City.  He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image-guided procedures, prostate artery embolization, laparoscopic and robotic surgery, and he has authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer, including focal therapy.

Recent publication - consensus on moving to Focal therapy Active Surveillance: https://pubmed.ncbi.nlm.nih.gov/33676851/

Dr Art Rastinehad’s website: https://drrastinehad.com/